Generation of a panel of monoclonal antibodies against atypical chemokine receptor CCX-CKR by DNA immunization

Journal of Pharmacological and Toxicological Methods

Volumn 63, Issue 3, 2011, Pages 250-257

  Takatsuka, Shogo ^a   Sekiguchi, Aya ^a   Tokunaga, Masayuki ^a   Fujimoto, Akira ^a   Chiba, Joe ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Atypical chemokine receptor; CCX CKR; DNA immunization; Hepatic cancer; Ligand like antibody; Monoclonal antibody panel

Indexed keywords

ANTIBODY; CHEMOCENTRYX CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR; EPITOPE; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 13E11; MONOCLONAL ANTIBODY 14F10; MONOCLONAL ANTIBODY 2F11; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; BINDING COMPETITION; CELL FATE; CELL SURFACE; CONTROLLED STUDY; DNA IMMUNIZATION; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; HYBRIDOMA CELL CULTURE; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; INTERNALIZATION; LIGAND BINDING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; COS CELLS; DNA; DRUG DISCOVERY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FLOW CYTOMETRY; HELA CELLS; HEPATOCYTES; HUMANS; IMMUNIZATION; IMMUNOPRECIPITATION; MICE; MICE, INBRED BALB C; RECEPTORS, CCR;

EID: 79954490711     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2010.12.003     Document Type: Article

References (21)

1. Aihara H., Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nature Biotechnology 1998, 16:867-870.
2. Ainai A., Kawase T., Ida A., Maeda Y., Ohba H., Ikeda Y., et al. Renewal of EBV-hybridoma method: Efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells. Human Antibodies 2006, 15:139-154.
3. Choe H., Farzan M. Chapter 7. Tyrosine sulfation of HIV-1 coreceptors and other chemokine receptors. Methods in Enzymology 2009, 461:147-170.
4. Comerford I., Milasta S., Morrow V., Milligan G., Nibbs R. The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro. European Journal of Immunology 2006, 36:1904-1916.
5. Comerford I., Nibbs R.J., Litchfield W., Bunting M., Harata-Lee Y., Haylock-Jacobs S., et al. The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses. Blood 2010, 116:4130-4140.
6. Feng L.Y., Ou Z.L., Wu F.Y., Shen Z.Z., Shao Z.M. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clinical Cancer Research 2009, 15:2962-2970.
7. Fujimoto A., Takatsuka S., Ishida I., Chiba J. Production of human antibodies to native cytokine receptors using the genetic immunization of KM mice. Human Antibodies 2009, 18:75-80.
8. Gosling J., Dairaghi D.J., Wang Y., Hanley M., Talbot D., Miao Z., et al. Cutting edge: Identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. Journal of Immunology 2000, 164:2851-2856.
9. Hansell C.A., Simpson C.V., Nibbs R.J. Chemokine sequestration by atypical chemokine receptors. Biochemical Society Transactions 2006, 34:1009-1013.
10. Haraldsen G., Rot A. Coy decoy with a new ploy: Interceptor controls the levels of homeostatic chemokines. European Journal of Immunology 2006, 36:1659-1661.
11. Heinzel K., Benz C., Bleul C.C. A silent chemokine receptor regulates steady-state leukocyte homing in vivo. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:8421-8426.
12. Herweijer H., Wolff J.A. Gene therapy progress and prospects: Hydrodynamic gene delivery. Gene Therapy 2007, 14:99-107.
13. Mantovani A., Bonecchi R., Locati M. Tuning inflammation and immunity by chemokine sequestration: Decoys and more. Nature Reviews. Immunology 2006, 6:907-918.
14. McMahon J.M., Signori E., Wells K.E., Fazio V.M., Wells D.J. Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase - Increased expression with reduced muscle damage. Gene Therapy 2001, 8:1264-1270.
15. Morita S., Kojima T., Kitamura T. Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Therapy 2000, 7:1063-1066.
16. Schimanski C.C., Bahre R., Gockel I., Junginger T., Simiantonaki N., Biesterfeld S., et al. Chemokine receptor CCR7 enhances intrahepatic and lymphatic dissemination of human hepatocellular cancer. Oncology Reports 2006, 16:109-113.
17. Shields J.D., Fleury M.E., Yong C., Tomei A.A., Randolph G.J., Swartz M.A. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 2007, 11:526-538.
18. Townson J.R., Nibbs R.J. Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP-3beta/mCCL19: Comparison to human CCX-CKR. European Journal of Immunology 2002, 32:1230-1241.
19. Wang J., Ou Z.L., Hou Y.F., Luo J.M., Shen Z.Z., Ding J., et al. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene 2006, 25:7201-7211.
20. Wilson J.L., Burchell J., Grimshaw M.J. Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor A and hypoxia-inducible factor-1. Cancer Research 2006, 66:11802-11807.
21. Wu F.Y., Ou Z.L., Feng L.Y., Luo J.M., Wang L.P., Shen Z.Z., et al. Chemokine decoy receptor d6 plays a negative role in human breast cancer. Molecular Cancer Research 2008, 6:1276-1288.